109 related articles for article (PubMed ID: 26975214)
1. PPARγ helix 12 exhibits an antagonist conformation.
Fratev F
Phys Chem Chem Phys; 2016 Apr; 18(13):9272-80. PubMed ID: 26975214
[TBL] [Abstract][Full Text] [Related]
2. Conformational Diversity of the Helix 12 of the Ligand Binding Domain of PPARγ and Functional Implications.
Batista MR; Martínez L
J Phys Chem B; 2015 Dec; 119(50):15418-29. PubMed ID: 26598113
[TBL] [Abstract][Full Text] [Related]
3. Activation helix orientation of the estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.
Fratev F
Phys Chem Chem Phys; 2015 May; 17(20):13403-20. PubMed ID: 25927714
[TBL] [Abstract][Full Text] [Related]
4. PPARγ non-covalent antagonists exhibit mutable binding modes with a similar free energy of binding: a case study.
Fratev F
J Biomol Struct Dyn; 2017 Feb; 35(3):476-485. PubMed ID: 26872742
[TBL] [Abstract][Full Text] [Related]
5. Mode of peroxisome proliferator-activated receptor γ activation by luteolin.
Puhl AC; Bernardes A; Silveira RL; Yuan J; Campos JL; Saidemberg DM; Palma MS; Cvoro A; Ayers SD; Webb P; Reinach PS; Skaf MS; Polikarpov I
Mol Pharmacol; 2012 Jun; 81(6):788-99. PubMed ID: 22391103
[TBL] [Abstract][Full Text] [Related]
6. Structural and Dynamical Insight into PPARγ Antagonism: In Silico Study of the Ligand-Receptor Interactions of Non-Covalent Antagonists.
Fratev F; Tsakovska I; Al Sharif M; Mihaylova E; Pajeva I
Int J Mol Sci; 2015 Jul; 16(7):15405-24. PubMed ID: 26184155
[TBL] [Abstract][Full Text] [Related]
7. Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor α/γ.
dos Santos JC; Bernardes A; Giampietro L; Ammazzalorso A; De Filippis B; Amoroso R; Polikarpov I
J Struct Biol; 2015 Sep; 191(3):332-40. PubMed ID: 26185032
[TBL] [Abstract][Full Text] [Related]
8. Agonism activities of lyso-phosphatidylcholines (LPC) Ligands binding to peroxisome proliferator-activated receptor gamma (PPARγ).
Wang J; Wang B; Zhang Y
J Biomol Struct Dyn; 2020 Feb; 38(2):398-409. PubMed ID: 31025599
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of nuclear receptor Helix-12 switch of transcription activation by modeling time-resolved fluorescence anisotropy decays.
Batista MR; Martínez L
Biophys J; 2013 Oct; 105(7):1670-80. PubMed ID: 24094408
[TBL] [Abstract][Full Text] [Related]
10. Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists.
Liberato MV; Nascimento AS; Ayers SD; Lin JZ; Cvoro A; Silveira RL; Martínez L; Souza PC; Saidemberg D; Deng T; Amato AA; Togashi M; Hsueh WA; Phillips K; Palma MS; Neves FA; Skaf MS; Webb P; Polikarpov I
PLoS One; 2012; 7(5):e36297. PubMed ID: 22649490
[TBL] [Abstract][Full Text] [Related]
11. PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix.
Frkic RL; Marshall AC; Blayo AL; Pukala TL; Kamenecka TM; Griffin PR; Bruning JB
iScience; 2018 Feb; 5():69-79. PubMed ID: 30123887
[TBL] [Abstract][Full Text] [Related]
12. Ligand-induced stabilization and activation of peroxisome proliferator-activated receptor gamma.
Gani OA; Sylte I
Chem Biol Drug Des; 2008 Jul; 72(1):50-7. PubMed ID: 18554251
[TBL] [Abstract][Full Text] [Related]
13. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
Hamuro Y; Coales SJ; Morrow JA; Molnar KS; Tuske SJ; Southern MR; Griffin PR
Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulations for human CAR inverse agonists.
Jyrkkärinne J; Küblbeck J; Pulkkinen J; Honkakoski P; Laatikainen R; Poso A; Laitinen T
J Chem Inf Model; 2012 Feb; 52(2):457-64. PubMed ID: 22233089
[TBL] [Abstract][Full Text] [Related]
16. Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism.
Zheng J; Corzo C; Chang MR; Shang J; Lam VQ; Brust R; Blayo AL; Bruning JB; Kamenecka TM; Kojetin DJ; Griffin PR
Structure; 2018 Nov; 26(11):1431-1439.e6. PubMed ID: 30146169
[TBL] [Abstract][Full Text] [Related]
17. A molecular switch regulating transcriptional repression and activation of PPARγ.
Shang J; Mosure SA; Zheng J; Brust R; Bass J; Nichols A; Solt LA; Griffin PR; Kojetin DJ
Nat Commun; 2020 Feb; 11(1):956. PubMed ID: 32075969
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of the transactivation deficiency of the human PPARγ F360L mutant associated with familial partial lipodystrophy.
Lori C; Pasquo A; Montanari R; Capelli D; Consalvi V; Chiaraluce R; Cervoni L; Loiodice F; Laghezza A; Aschi M; Giorgi A; Pochetti G
Acta Crystallogr D Biol Crystallogr; 2014 Jul; 70(Pt 7):1965-76. PubMed ID: 25004973
[TBL] [Abstract][Full Text] [Related]
19. Defining a conformational ensemble that directs activation of PPARγ.
Chrisman IM; Nemetchek MD; de Vera IMS; Shang J; Heidari Z; Long Y; Reyes-Caballero H; Galindo-Murillo R; Cheatham TE; Blayo AL; Shin Y; Fuhrmann J; Griffin PR; Kamenecka TM; Kojetin DJ; Hughes TS
Nat Commun; 2018 May; 9(1):1794. PubMed ID: 29728618
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of amorfrutins bound to the peroxisome proliferator-activated receptor γ.
de Groot JC; Weidner C; Krausze J; Kawamoto K; Schroeder FC; Sauer S; Büssow K
J Med Chem; 2013 Feb; 56(4):1535-43. PubMed ID: 23286787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
